Hugh Laverty
- Molecular Biology
- Rehabilitation top 2%
- Pharmacology top 2%
- Surgery
- Dermatology top 5%
- Co-authors
- Sharon O’KaneNick L. OcclestonMark W. J. FergusonJoanna B. WilsonChristopher E. GoldringDominic P. WilliamsTracey MasonCraig Lambert
- Topics
- Computational Drug Discovery Methods (4 papers)Wound Healing and Treatments (4 papers)Dermatologic Treatments and Research (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Hugh Laverty
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 439
- Rehabilitation 235
- Pharmacology 201
- Surgery 175
- Dermatology 145
Countries citing papers authored by Hugh Laverty
This map shows the geographic impact of Hugh Laverty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Laverty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Laverty more than expected).
Fields of papers citing papers by Hugh Laverty
This network shows the impact of papers produced by Hugh Laverty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Laverty. The network helps show where Hugh Laverty may publish in the future.
Co-authorship network of co-authors of Hugh Laverty
This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Laverty. A scholar is included among the top collaborators of Hugh Laverty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Laverty. Hugh Laverty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | IP Policy Forum: Intellectual Property Rights (IPR) In Collaborative Drug Development in the EU: Helping a European Public-Private Partnership Deliver - The Need for a Flexible Approach to IPR | 2 |
| 5 | 7 | |
| 6 | Building new models of drug discovery in Europe: The Innovative Medicines Initiative | 1 |
| 7 | Managing the challenge of chemically reactive metabolites in drug developmentbreakdown → | 338 |
| 8 | 7 | |
| 9 | 68 | |
| 10 | 175 | |
| 11 | 30 | |
| 12 | 49 | |
| 13 | 5 | |
| 14 | 215 | |
| 15 | 109 | |
| 16 | 26 | |
| 17 | 56 |
About Hugh Laverty
Hugh Laverty is a scholar working on Rehabilitation, Dermatology and Reproductive Medicine, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Wound Healing and Treatments (4 papers) and Dermatologic Treatments and Research (4 papers). The work is most often cited by research in Rehabilitation (235 citations), Pharmacology (201 citations) and Dermatology (145 citations). Hugh Laverty has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sharon O’Kane, Nick L. Occleston, Mark W. J. Ferguson, Joanna B. Wilson, Christopher E. Goldring, Dominic P. Williams, Tracey Mason, Craig Lambert, Dennis A. Smith and Stephen E. Clarke. Their work appears in journals such as The Lancet, Nature Reviews Drug Discovery and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.